Yahoo Malaysia Web Search

Sign In

Search results

  1. io.linkedin.com › company › cepheidCepheid | LinkedIn

    Jun 13, 2024 · Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly...

  2. Images

    • Cepheid Logo Download - AI - All Vector Logo
    • Feb 7, 2020 Santa Clara / CA / USA - Cepheid headquarters in Silicon ...
    • Cepheid Sign on Company HQ. Cepheid Inc is an American Molecular ...
    • Cepheid Sign on Company Headquarters. Cepheid Inc is an American ...

    View all

  3. tracxn.com › d › companiesCepheid - Company Profile - Tracxn

    Jun 25, 2024 · Developer of molecular diagnostic testing solutions. The company offers a wide range of tests segregated into three major categories Hospital-acquired infection, Critical Infectious diseases (multi-drug resistant TB (MDR-TB), influenza, RSV, and Enteroviral meningitis) Sexual Health, and Genetic Test (30 Minute Test for Genetic Risk of Thrombosis).

  4. www.medtechdive.com › news › cepheid-fda-nod-fingerstickCepheid wins FDA nod for fingerstick hepatitis C test

    Jun 28, 2024 · Cepheid said Thursday it received de novo authorization for the only molecular test in the U.S. to detect hepatitis C virus RNA directly from fingerstick blood samples. The Food and Drug Administration authorization positions healthcare professionals to diagnose hepatitis C at the point of care.

  5. www.fda.gov › news-events › press-announcementsFDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test

    Jun 27, 2024 · Today, the U.S. Food and Drug Administration granted marketing authorization to Cepheid for the Xpert HCV test and GeneXpert Xpress System, the first hepatitis C virus (HCV) test that can be used...

  6. Videos

    View all

  7. finance.yahoo.com › news › cepheid-receives-fda-authorizationCepheid Receives FDA Authorization with CLIA Waiver for Xpert®...

    Jun 27, 2024 · Cepheid announced today that it has received FDA De Novo marketing authorization and Clinical Laboratory Improvement Amendments (CLIA) Waiver approval for Xpert® HCV, the only molecular test in...

  8. lifesciencesintelligence.com › news › fda-grants-marketingFDA grants marketing authorization for point-of-care hepatitis C...

    6 days ago · Cepheid is now authorized to market the Xpert HCV tests and GeneXpert Xpress system for point-of-care hepatitis C testing.

  9. www.medicaldevice-developments.com › news › cepheid-gets-fdaCepheid gets FDA authorisation for its RNA-based hepatitis C test

    Jun 28, 2024 · US-based molecular diagnostics company Cepheid has received the US Food and Drug Administration (FDA) authorisation for its Xpert HCV test.